Revvity management check

RVTY · Health Care · Health Care Equipment · CEO Prahlad R. Singh

Filings as of

64
Management score, ranked 250th of 487 · 27th of 60 in Health Care4 good · 0 to watch · 2 flaggedStrongest: stable leadership · Weakest: CEO cost · Best and worst run in Health Care →

The seven checks

  • Flag

    Have owners done well?

    Trailed its chosen peersOwners$68Peers$105

    What $100 became since fiscal 2021

    620th
    Detail

    $100 invested at the start of fiscal 2021 grew to $68, against $105 for the peer group the company picked itself.

  • Good

    Does pay follow performance?

    Pay rose and fell with returns20212025

    Pay actually paid $100 value, each on its own scale

    8862nd
    Detail

    Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.76 with shareholder return. 1 means pay moved in step; below 0, the opposite way.

  • Flag

    What does the CEO cost owners?

    5.7% of net income

    $13.8m pay · $241.0m net income, FY2025

    0.1%1%3%10%
    016th
    Detail

    $13.8m of reported pay in fiscal 2025, against $241.0m of net income.

  • n/a

    Do they own the stock?

    No recent CEO filing
    ——

    Light activity: no buys, $1.3m sold in six months. 4 of 4 sales ran on pre-arranged 10b5-1 plans.

  • Good

    Are owners being diluted?

    Share count shrinking2021 · 117m2025 · 117m

    Diluted shares −3.3% a year; flagged above +2%

    0%10%20%

    Stock pay 0.8% of revenue

    9282nd
    Detail

    Diluted shares changed -3.3% a year over the last three fiscal years. Stock-based pay was 0.8% of revenue in the latest year.

  • Good

    Is leadership stable?

    2 leadership filings in 3 years

    2 filings under 8-K 5.02 in 3 years

    0101420+

    CEO: Prahlad R. Singh

    100100th
    Detail

    CEO in the pay table: Prahlad R. Singh. 2 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.

  • Good

    Are the books clean?

    No red flags on file

    Since 2021

    • 0Restated
    • 0Auditor changes
    • 0Late filings
    • 010-K amended
    100100th
    Detail

    No restatements, auditor changes or late filings since 2021.

  • Reading the scores

    Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.

    Hover a chart for its figures. Detail has the full reading.

Pay versus performance

From the proxy statement filed March 16, 2026.

CEO pay as reportedActually paid ⓘWhat $100 becamePeer group the company chose
$0$11.2m$22.4m$10020212022202320242025$68$105

Pay tied most to Average Non-COVID Organic Revenue Growth

Other key measuresAdjusted Operating Margin ExpansionOrganic Revenue GrowthAdjusted EPSFree Cash Flow Conversion

Show the figures
Fiscal yearCEOCEO payActually paidOther executives (avg)$100 becamePeersNet income
2025Prahlad R. Singh$13.8m$5.8m$3.9m$68$105$241.0m
2024—$11.9m$11.5m$2.9m$79$100$270.0m
2023—$9.1m$3.6m$2.2m$77$104$693.0m
2022—$10.6m$1.8m$2.1m$98$107$569.0m
2021—$9.7m$22.4m$2.4m$140$139$943.0m

Insiders and the CEO's stakeQuiet

Light activity: no buys, $1.3m sold in six months. 4 of 4 sales ran on pre-arranged 10b5-1 plans.

Open-market trades by officers and directors since May 21, 2026.

  • SoldTajinder S VohraPlease See Remarks · 10b5-1 plan$1.0mSep 16, 2026
  • SoldMaxwell KrakowiakPlease See Remarks · 10b5-1 plan$236kSep 21, 2026
  • SoldAnita GonzalesVP and CAO · 10b5-1 plan$22kOct 1, 2026

Leadership and governance on file

20222023202420252026Leadership 4Votes 5
All 4 filings

Latest shareholder vote results: May 1, 2026, including the say-on-pay vote.

Where the money went

2021–2025: $1.9bn returned to owners in buybacks and dividends, 70% of net income, and $183.3m of pay in stock.

Net incomeBuybacksDividendsStock-based payDiluted shares
$0$471.6m$943.2m20212022202320242025Shares117m126m125m123m117m
Show the figures
Fiscal year20212022202320242025
Revenue$3.8bn$3.3bn$2.8bn$2.8bn$2.9bn
Net income$943.2m$569.2m$693.1m$270.4m$241.2m
Stock-based pay$29.7m$51.5m$41.4m$37.8m$22.8m
Buybacks$73.1m$80.6m$388.9m$369.6m$820.8m
Dividends$32.4m$35.3m$35.0m$34.5m$32.8m
Diluted shares117m126m125m123m117m

Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.